Sputnik V will be subject to price controls: Government officials

Russia’s Covid vaccine Sputnik V will be subject to price controls and cost-effective, a government official said amid negotiations with Dr Reddy’s Labs, which will ship the doses into the country, writes Teena Thacker. While local companies will be able to determine price of Sputnik for export, domestic sales must be affordable, officials said.

“ In India, it has to be accessibility, affordability and availability,” said Balram Bhargava, director general, ICMR. India will get 50 million doses of Sputnik by the end of May, said Kirill Dmitriev, CEO of RDIF.